| 7. Apply understanding of the changes to coagulation, including testing and monitoring therapeutic management, in the following special situations: |
|
1 new discussion post (1 published)
Sign in to view your progression
|
|
7.1 Liver disease
|
|
|
7.2 Autoimmune diseases that impact on thrombosis and hemostasis (e.g. Lupus Anticoagulants, Systemic Lupus Erythematosus)
|
|
|
7.3 Trauma-associated coagulopathies and massive transfusions
|
|
|
7.4 HIT (4 T-score, screening and confirmations tests)
|
|
|
7.5 Pregnancy (during the pregnancy and postpartum)
|
|
|
7.6 / 7.7: Neonates / Pediatrics
|
|
|
7.8 Cancer and hematology malignancies
|
|
|
7.9 Thrombotic microangiopathies
|
|
|
7.10 Inflammation, infection-associated coagulopathies, disseminated intravascular coagulation
|
|
|
7.11 Acquired coagulopathies including heart valve disease, Extracorporeal Membrane Oxygenation or acquired specific factor inhibitors (e.g. Anti-FVIII antibodies)
|
|
|
7.12 Perioperative management of thrombotic and hemostatic disorders
|
|
|
7.13 Renal disorders
|
|
{{ help_message }}
{{filter}}